DUBLIN, Dec. 21, 2015 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/rvb3gd/europe_psoriasis) has announced the addition of the "Europe Psoriasis Market Highlights - 2015" report to their offering.
The report, 'Europe Psoriasis Market Highlights - 2015', provides an analysis of the psoriasis market in Europe, plus the competitive landscape and psoriasis drug sales forecast for the region.
Highlights of the Research:
- Marketed Psoriasis Drugs in Europe
- Europe Psoriasis Market Analysis
- Psoriasis Drugs Sales Analysis in Europe
- Competitive Landscape in Europe Psoriasis market
- Psoriasis Late Stage Pipeline
- Europe Psoriasis Market Forecast
- Psoriasis Drugs Sales Forecast in Europe
- Future Competitive Landscape
Benefits of this Report:
- Identify drugs marketed in Europe for treating psoriasis including trade name, molecule name, and company.
- Find out estimates for Europe psoriasis market size in 2014, key products and their sales, and how the market and products advanced from 2011. You will benefit from our accurate country and indication level valuation of products and the market.
- You will know the market share of leading psoriasis brands in Europe, including generics share.
- Find out pipeline products in clinical trial phase 3 and phase 2 for the treatment of psoriasis. Our coverage includes molecule, mechanism of action, and the company.
- Gain insights into how Europe psoriasis market will advance along with market forecast till 2020.
- Find out how psoriasis drugs will be positioned in Europe in 2020, with drug sales forecast and drug market share analysis for both marketed products and pipeline products.
1. Psoriasis - Disease Definition
2. Marketed Psoriasis Drugs in Europe
3. Europe Psoriasis Market Analysis
4. Competitive Landscape in Europe Psoriasis Market
5. Europe Psoriasis Market - Future Market Outlook
For more information visit http://www.researchandmarkets.com/research/rvb3gd/europe_psoriasis
Laura Wood, +353-1-481-1716, email@example.com
SOURCE Research and Markets